Instem Buys Clinical Trial Software Developer Logos

Instem Group has acquired Logos Technologies Inc., a company that makes software for managing early phase clinical studies.

London-based Logos provides its services to pharmaceutical, biotechnology and clinical research organizations. The company also develops mobile data-inputting software. Terms of the deal were not disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.